Literature DB >> 22469988

miR-143 regulates hexokinase 2 expression in cancer cells.

A Peschiaroli1, A Giacobbe, A Formosa, E K Markert, L Bongiorno-Borbone, A J Levine, E Candi, A D'Alessandro, L Zolla, A Finazzi Agrò, G Melino.   

Abstract

Tumor cells activate pathways that facilitate and stimulate glycolysis even in the presence of adequate levels of oxygen in order to satisfy their continuous need of molecules, such as nucleotides, ATP and fatty acids, necessary to support their rapid proliferation. Accordingly, a variety of human tumors are characterized by elevated expression levels of the hexokinase 2 isoform (HK2). Although different molecular mechanisms, including genetic and epigenetic mechanisms, have been suggested to account for the altered expression of HK2 in tumors, the potential role of microRNAs (miRNAs) in the regulation of HK2 expression has not been evaluated. Here, we report that miR-143 inhibits HK2 expression via a conserved miR-143 recognition motif located in the 3'-untranslated region (3'UTR) of HK2 mRNA. We demonstrate that miR143 inhibits HK2 expression both in primary keratinocytes and in head and neck squamous cell carcinoma (HNSCC)-derived cell lines. Importantly, we found that miR-143 inversely correlates with HK2 expression in HNSCC-derived cell lines and in primary tumors. We also report that the miRNA-dependent regulation of hexokinase expression is not limited to HK2 as miR-138 targets HK1 via a specific recognition motif located in its 3'UTR. All these data unveil a new miRNA-dependent mechanism of regulation of hexokinase expression potentially important in the regulation of glucose metabolism of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469988     DOI: 10.1038/onc.2012.100

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  75 in total

1.  MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene.

Authors:  Rong Fang; Tian Xiao; Zhaoyuan Fang; Yihua Sun; Fei Li; Yijun Gao; Yan Feng; Li Li; Ye Wang; Xiaolong Liu; Haiquan Chen; Xin-Yuan Liu; Hongbin Ji
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.

Authors:  Wenfeng Li; Zhengyang Xu; Junfeng Hong; Yunsheng Xu
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

Review 3.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Authors:  H Lincet; P Icard
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 4.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

Review 5.  Epigenetics of oral and oropharyngeal cancers.

Authors:  Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi
Journal:  Biomed Rep       Date:  2018-07-27

6.  MicroRNA regulation of CD8+ T cell responses.

Authors:  John D Gagnon; K Mark Ansel
Journal:  Noncoding RNA Investig       Date:  2019-08-26

7.  Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.

Authors:  Yun-Yong Park; Sang-Bae Kim; Hee Dong Han; Bo Hwa Sohn; Ji Hoon Kim; Jiyong Liang; Yiling Lu; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Gordon B Mills; Anil K Sood; Ju-Seog Lee
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

8.  miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.

Authors:  Yuanzeng Zhu; Gang Wu; Wenfeng Yan; Han Zhan; Peichun Sun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 9.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

Review 10.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.

Authors:  Zhaoyong Li; Huafeng Zhang
Journal:  Cell Mol Life Sci       Date:  2015-10-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.